Eu2P trainings are provided and updated by a unique partnership of seven Universities, fifteen pharmaceutical companies, the French and the European medicines agencies. It is designed for graduate and postgraduate students in health and life sciences, for healthcare professionals and for non-specialists and gathers experts from research groups of high repute, used to work together and involved in European network projects and international societies.
All Eu2P courses are modular, delivered in English and online for maximum flexibility and compliance with on-the-job training and world locations.
Master, PhD and Certificate are jointly awarded by Eu2P academic partners and recognized by all Eu2P regulatory and industrial partners.
Eu2P is funded by the European Commission through the Innovative Medicines Initiative to provide a common understanding in benefits and risks of medicines to all stakeholders.